{
    "code": "60001034",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001034",
    "time": "2021-09-17 03:49:05",
    "許可證字號": "衛部菌疫輸字第001034號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/11\/17",
    "發證日期": "105\/11\/17",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA06000103401",
    "中文品名": "安潰悠凍晶注射劑300毫克",
    "英文品名": "Entyvio Powder for Concentrate for Solution for Infusion",
    "適應症": "適用於治療以下的成人病人：\r\n(1) 中度至重度活性潰瘍性結腸炎。\r\n(2) 中度至重度活性克隆氏症。\r\n對腫瘤壞死因子 (TNF) 阻斷劑或免疫調節藥物治療反應不佳、失去治療反應或無法耐受；或對皮質類固醇治療反應不佳、無法耐受或證實發生依賴性。",
    "劑型": "243凍晶注射劑",
    "包裝": "300毫克玻璃小瓶裝 100瓶以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "110\/11\/17",
    "主成分略述": "Vedolizumab",
    "限制項目": "02輸　入 1D須執行風險管理計畫 1E須執行Phase IV Study 5F免除銜接性試驗",
    "申請商名稱": "1406701200  台灣武田藥品工業股份有限公司",
    "申請商地址": "台北市中山區南京東路三段217號7樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0619000  TAKEDA PHARMACEUTICAL COMPANY LIMITED, HIKARI PLANT",
            "製造廠廠址": "4720, TAKEDA, MITSUI, HIKARI, YAMAGUCHI 743-8502, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "成品製造廠"
        },
        {
            "製造廠名稱": "FUS0300000  HOSPIRA INC.",
            "製造廠廠址": "1776 NORTH CENTENNIAL DRIVE, MCPHERSON, KANSAS 67460, USA",
            "製造廠公司地址": "275 NORTH FIELD DRIVE, P.O. BOX 5045, LAKE FOREST, IL 60045-5045, USA",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FAT0008000  TAKEDA AUSTRIA GMBH",
            "製造廠廠址": "ST. PETER-STRASSE 25, 4020 LINZ, AUSTRIA",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRIA",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "FIT0402000  PATHEON ITALIA S.P.A.",
            "製造廠廠址": "2 TRAV. SX VIA MOROLENSE, 5-03013 FERENTINO (FR), ITALY",
            "製造廠公司地址": "",
            "製造廠國別": "ITALY",
            "製程": "成品製造廠"
        },
        {
            "製造廠名稱": "FUS0508000  LONZA BIOLOGICS, INC.",
            "製造廠廠址": "101 INTERNATIONAL DRIVE PEASE INTERNATIONAL TRADEPORT PORTSMOUTH, NEW HAMPSHIRE, U.S. 03801",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "主成分(drug substance)製造廠"
        },
        {
            "製造廠名稱": "FUS0850000  AbbVie Bioresearch Center",
            "製造廠廠址": "100 Research Drive, Worcester, MA 01605, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "CCC號列": "30021500005 免疫產品，具有劑量或零售包裝式樣者Immunological products, put up in measured doses or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200082200",
            "成分名稱": "Vedolizumab",
            "含量描述": "",
            "含量": "300.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Att3. Entyvio US202003CCDS6TW01 A3-110-08-27.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001034&Seq=004&Type=9"
        },
        {
            "title": "Att4. Entyvio label-109-12-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001034&Seq=006&Type=8"
        },
        {
            "title": "Att4. Entyvio carton-109-12-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001034&Seq=005&Type=8"
        }
    ]
}